top of page
Patient on Scale

Weight Loss

Semaglutide & Tirzepatide

Semaglutide and Tirzepatide acts on the body differently than insulin. Semaglutide and Tirzepatideis a member of the GLP-1 class of medications, and has acts to reduce hunger and weight. Semaglutide and Tirzepatide slows the rate at which food is transferred from the stomach to the intestines (called gastric emptying), which generally makes you feel full sooner and longer, so you eat less. The medication also passes through the bloodstream into the brain, where it decreases both food intake and appetite.

Checking Weight

Initial Evalution Includes :

  • Consultation

  • Medical History Review

  • Brief Health Exam/Systems Review

  • Weigh-in

  • Program Implementation

  • Semaglutide or Tirzepatide Prescription first 10 Weeks


Evaluation & Prescription Dose as low as


a month

Enjoying Nature

How Does Semaglutide & Tirzepatide Work?

In large RCTs, patients receiving semaglutide or Tirzepatide, 2.4 mg, lost a mean of 6% of their weight by week 12 and 12% of their weight by week 28. Results vary, but many people start feeling the effects of the Semaglutide and Tirzepatide at the first dose and should start experiencing weight loss within the first two weeks of the program. In a 68-week trial published in the New England Journal of Medicine in March 2021, obese or overweight adults who took semaglutide or Tirzepatide had a 15% decrease on body weight, and also experienced improvements in physical function and risk factors for heart disease. 


Please make sure you fill out the intake forms 24 hours before your first visit - Brooke Carter (CRNP)

bottom of page